2Bousquet J, lockey R, Mailing H J. A WHO position paper. Allergen irnmunotherapy: therapeutic vaccines for allergic dis- ease [J] .Allergy Clin Immunol, 1998, 102(Suppl): 558.
3Bousquet J, Khaltaev N, Cruz A A, et al. Allergic rhinitis and its impact on asthma(ARIA) 2008 update[J]. Allergy, 2008, 63(Suppl) : 8.
4Calamita Z, Saconato H, Peld A B, et al. Efficacy of sublin gual iramunotherapy in asthma: systematic review of random ized clinical trials using the cochrane collaboration method[J ] Allergy, 2006, 61(10): 1162.
2Wilson DR, Lima MT, Durham SR Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis [J]. Allergy, 2005,60(4) : 4-12.
3Bousquet J, Lockey R, Mailing HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic disease[J]. Allergy (Suppl), 1998,53(8) : 1-42.
4Marogna M, Spadolini I, Massolo A,et al. Ramdomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more[J]. Allergy, 2004,59(3 Suppl) : 1205-1210.
5Khinchi MS, Poulsen LK, Carat F,et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, doubleblind, double-dummy study[J]. Allergy, 2004,59(5 Suppl) : 45-53.
6Passalaqua G, Guerra L, Pasquali M,et al. Efficacy and safety of sublingual immunotherapy[J]. Ann Allergy Asthma Immunol, 2004,93(4) :3-12.
7Gidaro GB, Marcucci F, Sensi L,et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies[J]. Clin Exp Allergy,2005,35(6):505-571.
8Passalaqua G, Canonica GW. Long-lasting clinical efficacy of allergen specific immunotherapy [J]. Allergy, 2002, 57 ( 4 ) : 275-276.
9Di Rienzo V, Marcucci F, Paccinelli P, et aL Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study[J]. Clin Exp Allergy, 2003,33(3) : 206-210.
